Our Research|KazIOR

Our Research

KazIOR actively participates in international clinical studies and projects, collaborating with leading pharmaceutical companies and research organizations. The goal is to implement personalized treatment approaches, improve screening, and advance molecular-genetic diagnostics.

Current Research Projects for 2025:

Prospective observational international registry of patients with newly diagnosed peripheral T-Cell Lymphoma+

Investigators: S.A. Dzazyltaeva, Hematology Center Physicians, 4 Residents
Study Identifier: ClinicalTrials.gov Identifier: NCT03964480

Improvement of Mammology Screening

Investigators: A.Zh. Zhylkaidarova, N.S. Gorbunova, Zh.M. Amankulov
International Partners: C3Medical

Testing Patients with HR+ HER2- and TNBC for gBRCA1/2 Mutations via NGS

Investigators: M.G. Orazgalieva, S.O. Osikbayeva, G.G. Rakhmatulla
International Partners: Pfizer

Providing Early Access to HRD Testing for Patients with Ovarian and Breast Cancer

Investigators: M.G. Orazgalieva, S.O. Osikbayeva, G.G. Rakhmatulla, N.A. Spandiyarova
International Partners: AstraZeneca

Detection of EGFR T790M Mutation (Liquid Biopsy) in Lung Cancer Patients

Investigators: M.G. Orazgalieva, S.O. Osikbayeva, G.G. Rakhmatulla, S.T. Aliyeva
International Partners: AstraZenecaa

HPV Testing – Screening

Investigators: A.Zh. Zhylkaidarova, N.S. Gorbunova
International Partners: Roche